Hämodilution bei der Behandlung der intrauterinen Dystrophie

It was the aim of the study to show that HES (Hydroxy-Ethyl-Starch) in intrauterine dystrophy identified by ultrasonography can increase fetal growth. Twenty pregnant women were treated in two groups (outpatients versus inpatients). Clinically, the result was satisfying